Journal
NEURON
Volume 79, Issue 5, Pages 887-902Publisher
CELL PRESS
DOI: 10.1016/j.neuron.2013.06.036
Keywords
-
Categories
Funding
- National Institutes of Health
- Falk Medical Research Trust
- Alzheimer's Association
Ask authors/readers for more resources
Soluble amyloid-beta oligomers (A beta o) trigger Alzheimer's disease (AD) pathophysiology and bind with high affinity to cellular prion protein (PrPC). At the postsynaptic density (PSD), extracellular A beta o bound to lipid-anchored PrPC activates intracellular Fyn kinase to disrupt synapses. Here, we screened transmembrane PSD proteins heterologously for the ability to couple A beta o-PrPC with Fyn. Only coexpression of the metabotropic glutamate receptor, mGluR5, allowed PrPC-bound A beta o to activate Fyn. PrPC and mGluR5 interact physically, and cytoplasmic Fyn forms a complex with mGluR5. A beta o-PrPC generates mGluR5-mediated increases of intracellular calcium in Xenopus oocytes and in neurons, and the latter is also driven by human AD brain extracts. In addition, signaling by A beta o-PrPC-mGluR5 complexes mediates eEF2 phosphorylation and dendritic spine loss. For mice expressing familial AD transgenes, mGluR5 antagonism reverses deficits in learning, memory, and synapse density. Thus, A beta o-PrPC complexes at the neuronal surface activate mGluR5 to disrupt neuronal function.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available